Workplace Wellness Can Help Reduce the Risk for Heart ProblemsVideo
Categories
- Allergy
- Alzheimer's Disease
- Arthritis
- Asthma
- Breast Cancer
- Cardio Health
- Cholesterol
- Cold and Flu
- Colon Cancer
- Diabetes
- Dieting
- Epilepsy
- Hair Loss
- Headache
- Heartburn
- HIV & AIDS
- Kidney Health
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Sclerosis
- Men's Health
- Mental Health
- Nutrition
- Osteoporosis
- Parkinson's Disease
- Prostate Health
- Skin Health
- Sleep Disorders
- Women's Health
- General
Leukemia Drug May Help Some Ovarian Cancer Patients
Posted on 11/12/2009, 09:00
By -- Randy Dotinga
Sprycel limited the growth of cancer cells in lab study
THURSDAY, Nov. 12 (HealthDay News) -- A drug for people with a form of leukemia holds promise as a possible treatment for ovarian cancer, new research suggests.
The drug dasatinib (Sprycel) is used to treat chronic myeloid leukemia. Researchers at the University of California at Los Angeles report that the drug limited the growth and invasive powers of ovarian cancer cells.
It also proved to have even more cancer-fighting powers when it was combined with chemotherapy and used to fight certain kinds of ovarian cancer cells known as Src dependent, according to the report published in the Nov. 10 issue of the BMJ.
Ovarian cancer is the most deadly cancer that strikes the female reproductive system and is expected to kill 15,500 women in the United States this year. The cancer is very difficult to treat.
"It is important to remember that this work is only on cancer cell lines, but it is significant enough that it should be used to justify clinical trials to confirm that women with this type of ovarian cancer could benefit," Gottfried Konecny, an assistant professor of hematology/oncology and first author of the study, said in a UCLA news release.
An estimated one-third of women with ovarian cancer have the type known as Src dependent.
"We were able to identify markers in the pre-clinical setting that would allow us to predict response to Sprycel," Konecny said. "These may help us in future clinical trials in selecting patients for studies of the drug."
More information
Learn more about ovarian cancer from the U.S. National Cancer Institute.
SOURCE: University of California Los Angeles, news release, Nov. 10, 2009
Copyright © 2009 ScoutNews, LLC. All rights reserved.
BigHealthTree.com Disclaimer
Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.
Some Parents May Hasten Death for Terminally Ill Children
Fitness Academics
Secondhand Smoke Increases Risk for Heart Disease in Kids
Toddlers Don't Learn Vocabulary From TV
Despite Worries, Most Parents Vaccinate Their Kids Anyway
Food Allergies Can Be Treated With the Allergen Foods
Signs of Heart Disease Could Be As Early as 3 in Obese Kids
The Number of Women Having Strokes is Rising
Preventative Mastectomy
Cases of Gestational Diabetes Are On the Rise
Nintendo Wii Could Be Therapy for Stroke Victims
Single Men Have An Increased Risk for Stroke
Fatty Foods Could Lead to Stroke in Older Women
Woman Gives Birth After Ovary Transplant

Comments (0):
Be the first to comment on this article.
Post a comment